HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis.

Abstract
The vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2), also called fetal liver kinase 1 (FLK1) in mice and kinase insert domain receptor (KDR) in humans, is an endothelial cell specific receptor tyrosine kinase that mediates lung cancer angiogenesis. We hypothesized that an active immunotherapy approach targeting FLK1 may inhibit lung cancer growth and metastasis. To test this hypothesis, we evaluated whether immune responses to FLK1 could be elicited in mice by immunization with an orally administered DNA vaccine encoding the extracellular domain (ECD) of FLK1 (pcDNA3.1-FLK1(ECD)) carried by attenuated Salmonella typhimurium. We found that the vaccine was effective at protective antitumor immunity in Lewis lung carcinoma models in mice by breaking immune tolerance to FLK1 self-antigen. Both FLK1-specific humoral and cellular immune responses against endothelial cells can be induced in mice by immunization with pcDNA3.1-FLK1(ECD). Immunization with pcDNA3.1-FLK1(ECD) resulted in tumor suppression and prolonged survival in mice challenged with Lewis lung carcinomas cells. Experimental pulmonary metastases were strongly inhibited in pcDNA3.1-FLK1(ECD) immunized mice challenged with Lewis lung carcinoma cells. Thus, we conclude that the plasmid DNA vaccine encoding the extracellular domain of FLK1 could be an important component of FLK1 DNA vaccine to prevent lung carcinoma recurrence and metastasis after surgery.
AuthorsShu Guang Zuo, Yan Chen, Zhi Ping Wu, Xin Liu, Chun Liu, Yong Chun Zhou, Cui Ling Wu, Cong Guo Jin, Yu Lan Gu, Jia Li, Xiao Qun Chen, Yong Li, Hui Ping Wei, Li Hua Li, Xi Cai Wang
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 33 Issue 2 Pg. 174-82 ( 2010) ISSN: 1347-5215 [Electronic] Japan
PMID20118536 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Vaccines
  • Cancer Vaccines
  • Vaccines, Attenuated
  • Vaccines, DNA
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Administration, Oral
  • Animals
  • Bacterial Vaccines (administration & dosage, immunology, therapeutic use)
  • Cancer Vaccines (administration & dosage, immunology, therapeutic use)
  • Carcinoma, Lewis Lung (enzymology, pathology, prevention & control, secondary)
  • Cell Line, Tumor
  • Drug Delivery Systems (methods)
  • Female
  • Gene Transfer Techniques
  • Mice
  • Mice, Inbred C57BL
  • Salmonella typhimurium (immunology)
  • Vaccines, Attenuated (administration & dosage, immunology, therapeutic use)
  • Vaccines, DNA (administration & dosage, immunology, therapeutic use)
  • Vascular Endothelial Growth Factor Receptor-2 (antagonists & inhibitors, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: